Comparison of epoetin alfa and darbepoetin alfa biological activity under different administration schedules in normal mice

被引:14
|
作者
Sasu, BJ [1 ]
Hartley, C [1 ]
Schultz, H [1 ]
McElroy, P [1 ]
Khaja, R [1 ]
Elliott, S [1 ]
Egrie, JC [1 ]
Browne, JK [1 ]
Begley, CG [1 ]
Molineux, G [1 ]
机构
[1] Amgen Inc, Dept Hematol, Thousand Oaks, CA 91320 USA
关键词
Aranesp (R); darbepoetin alfa; epoetin alfa; erythropoietic units; hemoglobin;
D O I
10.1159/000084446
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The unit of erythropoietic activity has long been the standard by which erythropoietic agents are judged, but the development of long-acting agents such as darbepoetin alfa has highlighted the shortcomings of this approach. To this point, we compared the in vivo activity of Epoetin alfa and darbepoetin alfa per microgram of protein core. Using the established mass-to-unit conversion for Epoetin alfa (1 mu g congruent to 200 U), we then calculated darbepoetin alfa activity in units. Activity varied with treatment regimen (1 mu g darbepoetin alfa congruent to 800 U for 3 times weekly dosing to 8,000 U for a single injection). This analysis reveals the inadequacy of evaluating darbepoetin alfa activity in terms of standard erythropoietic units. We therefore propose that for molecules with heightened biological activity, a more legitimate basis for comparison is the protein mass. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:163 / 174
页数:12
相关论文
共 12 条
  • [1] Clinical and economic comparison of epoetin alfa and darbepoetin alfa
    Morreale, A
    Plowman, B
    DeLattre, M
    Boggie, D
    Schaefer, M
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (03) : 381 - 395
  • [2] Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness
    Voils, Stacy A.
    Harpe, Spencer H.
    Brophy, Gretchen M.
    PHARMACOTHERAPY, 2007, 27 (04): : 535 - 541
  • [3] Comparison of effects of darbepoetin alfa and epoetin alfa on serum endothelin level and blood pressure
    Mehmet Kanbay
    Ali Akcay
    Tuncay Delibasi
    Burak Uz
    Arif Kaya
    Cemile Koca
    Faruk Turgut
    Nuket Bavbek
    Ebru Uz
    Murat Duranay
    Ramazan Yigitoglu
    Advances in Therapy, 2007, 24 : 346 - 352
  • [4] Comparison of effects of darbepoetin alfa and epoetin alfa on serum endothelin level and blood pressure
    Kanbay, Mehmet
    Akcay, Ali
    Delibasi, Tuncay
    Uz, Burak
    Kaya, Arif
    Koca, Cemile
    Turgut, Faruk
    Bavbek, Nuket
    Uz, Ebru
    Duranay, Murat
    Yigitoglu, Ramazan
    ADVANCES IN THERAPY, 2007, 24 (02) : 346 - 352
  • [5] Effects of different dialysis membranes on serum concentrations of epoetin alfa, darbepoetin alfa, enoxaparin, and iron sucrose during dialysis
    McMahon, LP
    Chester, K
    Walker, RG
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (03) : 509 - 516
  • [6] Comparison of Pain and Efficacy of Darbepoetin Alfa and Epoetin Beta Pegol Treatment in Patients Receiving Peritoneal Dialysis
    Otsuka, Tomoyuki
    Sakai, Yukinao
    Yui, Shizuka
    Sukegawa, Masami
    Suzuki, Anna
    Mugishima, Koji
    Sumi, Yuichiro
    Otsuka, Yusuke
    Tsuruoka, Shuichi
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2015, 82 (01) : 24 - 29
  • [7] A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy-associated anemia
    Steensma, David P.
    Dakhil, Shaker R.
    Novotny, Paul J.
    Sloan, Jeff A.
    Johnson, David B.
    Anderson, Daniel M.
    Mattar, Bassam I.
    Moore, Dennis F., Jr.
    Nikcevich, Daniel
    Loprinzi, Charles L.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (10) : 877 - 881
  • [8] A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer
    Schwartzberg, LS
    Yee, LK
    Senecal, FM
    Charu, V
    Tomita, D
    Wallace, J
    Rossi, G
    ONCOLOGIST, 2004, 9 (06) : 696 - 707
  • [9] Randomized comparison of epoetin alfa (40,000 U weekly) and darbepoetin alfa (200 μg every 2 weeks) in anemic patients with cancer receiving chemotherapy
    Waltzman, R
    Croot, C
    Justice, GR
    Fesen, MR
    Charu, V
    Williams, D
    ONCOLOGIST, 2005, 10 (08) : 642 - 650
  • [10] Differences in Proportion of N-acetyllactosamine and O-acetylated Sialic Acid Have No Significant Effect on the Pharmacokinetics and Biological Activity of Darbepoetin Alfa
    Lee, Won Jeong
    Oh, Hookeun
    Choi, Inseong
    Lee, Keunho
    Shin, Hyunwoo
    Lee, Yoon Jung
    Park, Jeehye
    Yang, Yoo Hee
    Ha, Gyong-Sik
    Lee, Dong-Eok
    Choi, Kang-Yell
    Choi, Eunyoung
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2022, 27 (02) : 244 - 252